当前位置:首页 - 行情中心 - 三力制药(603439) - 财务分析 - 现金流量表

三力制药

(603439)

  

流通市值:52.46亿  总市值:53.12亿
流通股本:4.04亿   总股本:4.09亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金378,199,568.481,858,198,458.161,326,555,727881,693,172.86
  收到的税费返还1,092,635.141,926,582.231,694,742.2323,521.23
  收到其他与经营活动有关的现金1,550,238.4359,772,017.7239,128,906.6320,400,752.17
  经营活动现金流入小计380,842,442.051,919,897,058.111,367,379,375.86902,117,446.26
  购买商品、接受劳务支付的现金70,179,722.84490,853,740.74399,230,830.01269,478,920.98
  支付给职工以及为职工支付的现金67,301,644.05319,776,028.09250,116,414.12176,636,190.75
  支付的各项税费65,069,684.13193,103,919.71139,405,239.75111,917,580.21
  支付其他与经营活动有关的现金164,697,605.83751,586,345.2528,563,256.81327,137,433.28
  经营活动现金流出小计367,248,656.851,755,320,033.741,317,315,740.69885,170,125.22
  经营活动产生的现金流量净额13,593,785.2164,577,024.3750,063,635.1716,947,321.04
二、投资活动产生的现金流量:
  取得投资收益收到的现金400,517.87657,842.82494,460.46421,672.37
  处置固定资产、无形资产和其他长期资产收回的现金净额-639,687.5458,987.5614,000
  收到的其他与投资活动有关的现金88,000,000103,015,00061,300,00054,400,000
  投资活动现金流入小计88,400,517.87104,312,530.3262,253,447.9655,435,672.37
  购建固定资产、无形资产和其他长期资产支付的现金5,206,19825,838,199.5723,814,915.9616,416,977.99
  投资支付的现金-206,830,000206,830,000190,830,000
  支付其他与投资活动有关的现金244,000,000100,079,654.0498,099,654.0450,990,000
  投资活动现金流出小计249,206,198332,747,853.61328,744,570258,236,977.99
  投资活动产生的现金流量净额-160,805,680.13-228,435,323.29-266,491,122.04-202,801,305.62
三、筹资活动产生的现金流量:
  取得借款收到的现金67,144,950.08570,543,303.5449,638,000355,857,527.76
  筹资活动现金流入小计67,144,950.08570,543,303.5449,638,000355,857,527.76
  偿还债务支付的现金104,204,676.5418,906,778.97276,481,778.97202,425,000
  分配股利、利润或偿付利息支付的现金4,524,802.65161,443,697.28155,606,886.5149,329,036.5
  其中:子公司支付给少数股东的股利、利润--645,894654,894
  支付其他与筹资活动有关的现金286,40011,760,182.3610,276,172.779,547,344
  筹资活动现金流出小计109,015,879.15592,110,658.61442,364,838.24361,301,380.5
  筹资活动产生的现金流量净额-41,870,929.07-21,567,355.117,273,161.76-5,443,852.74
五、现金及现金等价物净增加额-189,082,824-85,425,654.03-209,154,325.11-191,297,837.32
  加:期初现金及现金等价物余额389,417,360.31474,843,014.34474,845,014.34474,843,014.34
  期末现金及现金等价物余额200,334,536.31389,417,360.31265,690,689.23283,545,177.02
补充资料:
  净利润-48,153,602.74-85,391,334.02
  资产减值准备-129,825,096.73-1,710,772.88
  固定资产和投资性房地产折旧-53,951,010.1-27,648,662.56
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-53,951,010.1-27,648,662.56
  无形资产摊销-18,867,980.04-9,536,629.65
  长期待摊费用摊销-317,341.47-156,641.64
  处置固定资产、无形资产和其他长期资产的损失-115,565.58--92,043.74
  固定资产报废损失-31,973.43-27,956.34
  公允价值变动损失--155,822.2--110,145.21
  财务费用-25,304,530.19-11,023,547.47
  投资损失-2,772,299.71--285,716.66
  递延所得税--4,173,133.44-2,047,166.12
  其中:递延所得税资产减少--664,747.14-285,926.32
    递延所得税负债增加--3,508,386.3-1,761,239.8
  存货的减少-92,678,699.28--44,963,470.68
  经营性应收项目的减少-196,233,956.34-155,370,548.7
  经营性应付项目的增加--408,689,731.19--234,839,818.47
  其他-13,725,903.98-7,298,301.73
  不涉及现金收支的投资和筹资活动金额其他项目-3,848,216.64--
  现金的期末余额-389,417,360.31-283,545,177.02
  减:现金的期初余额-474,843,014.34-474,843,014.34
  现金及现金等价物的净增加额--85,425,654.03--191,297,837.32
公告日期2026-04-272026-04-272025-10-282025-08-28
审计意见(境内)标准无保留意见
TOP↑